Swiss National Bank Teva Pharmaceutical Industries LTD Transaction History
Swiss National Bank
- $137 Billion
- Q1 2025
A detailed history of Swiss National Bank transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Swiss National Bank holds 3,130,400 shares of TEVA stock, worth $51.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,130,400
Previous 3,127,900
0.08%
Holding current value
$51.8 Million
Previous $68.9 Million
30.21%
% of portfolio
0.03%
Previous 0.05%
Shares
31 transactions
Others Institutions Holding TEVA
# of Institutions
660Shares Held
627MCall Options Held
27.9MPut Options Held
21.8M-
Black Rock Inc. New York, NY43MShares$711 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E939MShares$646 Million39.53% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$625 Million5.98% of portfolio
-
Menora Mivtachim Holdings Ltd.29.2MShares$483 Million2.92% of portfolio
-
Exor Capital LLP London, X027.9MShares$461 Million12.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...